Nazila Mozammel
Overview
Explore the profile of Nazila Mozammel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tohidast M, Amini M, Doustvandi M, Hosseini S, Bilan F, Mozammel N, et al.
Bioimpacts
. 2025 Feb;
15:30255.
PMID: 39963562
Introduction: Colorectal cancer (CRC) is regarded as a serious global issue and is presently ranked second in the classification of gastrointestinal (GI) malignancies, with fast incidence and high mortality patterns....
2.
Zaer S, Aghamaali M, Najafi S, Hosseini S, Amini M, Doustvandi M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Jul;
398(1):533-542.
PMID: 39007927
As an aggressive malignancy, glioblastoma multiforme (GBM) is the most common type of brain tumor. The existing treatments have shown limited achievement in increasing the overall survival of patients. Therefore,...
3.
Mozammel N, Baghbani E, Amini M, Zaer S, Baghay Esfandyari Y, Tohidast M, et al.
Adv Pharm Bull
. 2024 Apr;
14(1):231-240.
PMID: 38585468
Purpose: MicroRNAs (miRNAs) are a group of small regulatory non-coding RNAs, which are dysregulated through tumor progression. let-7 and MIR-145 are both tumor suppressor microRNAs that are downregulated in a...
4.
Mozammel N, Amini M, Baradaran B, Bahojb Mahdavi S, Hosseini S, Mokhtarzadeh A
Pathol Res Pract
. 2023 Jan;
242:154290.
PMID: 36621158
MicroRNAs (miRNA) are a broad class of small, highly conserved non-coding RNAs that largely influence gene expression after transcription through binding to various target mRNAs. miRNAs are frequently dysregulated in...
5.
Baghay Esfandyari Y, Doustvandi M, Amini M, Baradaran B, Zaer S, Mozammel N, et al.
Reprod Sci
. 2021 Feb;
28(7):2036-2049.
PMID: 33569751
Cisplatin-based chemotherapy is commonly used for cervical cancer treatment. However, the development of chemoresistance is considered the main obstacle to the effectiveness of this therapeutic agent. MicroRNAs are illustrated to...